NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE2536.85-10.65 (-0.42 %)
PREV CLOSE ( ) 2547.50
OPEN PRICE ( ) 2546.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1605
TODAY'S LOW / HIGH ( )2525.00 2559.00
52 WK LOW / HIGH ( )1581.1 2745.55
NSE2539.40-7.45 (-0.29 %)
PREV CLOSE( ) 2546.85
OPEN PRICE ( ) 2540.00
BID PRICE (QTY) 2539.40 (88)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 287483
TODAY'S LOW / HIGH( ) 2523.05 2560.00
52 WK LOW / HIGH ( )1584.85 2744
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 15-07 1972
Management Info
Samir Mehta - Chairman - Managing Director
Registered Office

Address Torrent House,Off Ashram Road,,
Ahmedabad,
Gujarat-380009

Phone 079-26599000

Email investorservices@torrentpharma.com

Website www.torrentpharma.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
 Listing : BSE, NSE, MCX
NEWS
06Mar USFDA issues EIR to Torrent Pharmaceut
The United States Food and Drug Administration (USFDA) has successfully..
05Feb Torrent Pharmaceuticals hits 52-week h
Torrent Pharmaceuticals is currently trading at Rs. 2679.90, up by 155.2..
03Feb Torrent Pharmaceuticals reports 52% ri
Torrent Pharmaceuticals has reported results for third quarter ended Dec..
02Feb Torrent Pharmaceuticals informs about
Torrent Pharmaceuticals has informed that the Presentation on unaudited..
12Jan Torrent Pharmaceuticals informs about
Torrent Pharmaceuticals has informed that a meeting of the Board of Dire..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit297010520
Gross Profit 4300 15770
Operating Profit 690025470
Net Sales 2123076950
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1455.20 (10.00%)
M.Cap (Rs. in Cr)846.88
Solara Active Pharma (BSE)
 551.45 (16.32%)
M.Cap (Rs. in Cr)1985.01
Abbott India (BSE)
 26131.85 (0.29%)
M.Cap (Rs. in Cr)55528.36
Windlas Biotech (BSE)
 555.05 (6.97%)
M.Cap (Rs. in Cr)1154.42
Concord Biotech (BSE)
 1595.25 (1.05%)
M.Cap (Rs. in Cr)16688.90
MORE
Shareholding Pattern
PROMOTERS 71.25%
NON-INSTITUTION 7.36%
MUTUAL FUNDS/UTI 4.46%
FI/BANKS/INSURANCE 1.95%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.